E. Gonzalez‐Rodriguez

Spontaneous Vertebral Fractures in Males with Osteoporosis After Denosumab Discontinuation

D. Goulis, E. Tsiridis, O. Lamy, 2019, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

Severe spontaneous vertebral fractures after denosumab discontinuation: three case reports

O. Lamy, D. Stoll, B. Aubry-Rozier, 2016, Osteoporosis International.

The Benefit of Menopausal Hormone Therapy on Bone Density and Microarchitecture Persists After its Withdrawal.

P. Marques‐Vidal, P. Vollenweider, G. Waeber, 2016, The Journal of clinical endocrinology and metabolism.

Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women

O. Lamy, E. Gonzalez‐Rodriguez, Brengre Aubry-Rozier, 2017, Annals of Internal Medicine.

Severe Rebound-Associated Vertebral Fractures After Denosumab Discontinuation: 9 Clinical Cases Report

D. Hans, O. Lamy, D. Stoll, 2017, The Journal of clinical endocrinology and metabolism.

The lumbar spine age-related degenerative disease influences the BMD not the TBS: the Osteolaus cohort

D. Hans, M. Metzger, O. Lamy, 2017, Osteoporosis International.

Postmenopausal women with osteoporosis consume high amounts of vegetables but insufficient dairy products and calcium to benefit from their virtues: the CoLaus/OsteoLaus cohort

D. Hans, O. Lamy, D. Hans, 2019, Osteoporosis International.

Sixty spontaneous vertebral fractures after denosumab discontinuation in 15 women with early-stage breast cancer under aromatase inhibitors

K. Zaman, O. Lamy, D. Stoll, 2019, Breast Cancer Research and Treatment.

Alendronate after denosumab discontinuation in women previously exposed to bisphosphonates was not effective in preventing the risk of spontaneous multiple vertebral fractures: two case reports

O. Lamy, P. Aguado, D. Stoll, 2019, Osteoporosis International.

Raloxifene Has No Efficacy in Reducing the High Bone Turnover and the Risk of Spontaneous Vertebral Fractures after Denosumab Discontinuation

O. Lamy, D. Stoll, E. Gonzalez-Rodriguez, 2018, Case reports in rheumatology.

OP0085 CAN WE AVOID THE LOSS OF BONE MINERAL DENSITY ONE YEAR AFTER DENOSUMAB DISCONTINUATION? THE REOLAUS BONE PROJECT

D. Hans, O. Lamy, D. Stoll, 2019, Oral Presentations.

Maintenance of bone resorption markers in the low premenopausal range during the year following denosumab discontinuation is associated to bone density preservation. The ReoLaus study.

O. Lamy, B. Aubry-Rozier, G. Liebich, 2023, Bone.

Underestimation of Vertebral Fractures After Denosumab Discontinuation

O. Lamy, E. Gonzalez-Rodriguez, E. Gonzalez‐Rodriguez, 2018, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.